4.96 -0.06 (-1.19%)
PCYC
Stock Details
Last Trade:4.96 Change:-0.06 (-1.19%) Prev Close:5.02 Open: 5.04 Days Range:4.87 – 5.04 52 Week Range: 0.57 - 5.02 Volume:241748 P/E: N/AEPS:-0.75
View AllRecent Alerts 02/10/10
Recent Alert on 01/29/10 at 7:04am
Merriman Curhan Ford Initiates Coverage on Pharmacyclics (PCYC) with a Buy; New Management, New Capital, New Pipeline
Merriman Curhan Ford Initiates Coverage on Pharmacyclics (PCYC) with a Buy; New Management, New Capital, New Pipeline
Merriman Curhan Ford initiates coverage on Pharmacyclics, Inc. (Nasdaq: PCYC) with a Buy rating. Price target range $5.50-7.50. Merriman analyst says, "Pharmacyclics is a small-cap biopharmaceutical company that has been abandoned and forgotten by... Read More
Recent Alert on 12/14/09 at 10:29am
BWS Financial Maintains a 'Buy' on Pharmacyclics (PCYC); Raises PT
BWS Financial Maintains a 'Buy' on Pharmacyclics (PCYC); Raises PT
Recent Alert on 12/08/09 at 10:11am
Morning Movers 12/08: RWC, SNSS, QDHC, TLB Higher; PIP, ADAT, KR, BANR, IPSU, MTN Lower
Morning Movers 12/08: RWC, SNSS, QDHC, TLB Higher; PIP, ADAT, KR, BANR, IPSU, MTN Lower
View AllRecent Press Releases
Press Release on 02/08/10 at 2:30pm
Pharmacyclics Announces Date of Second Quarter Fiscal 2010 Financial Results and Conference Call
Pharmacyclics Announces Date of Second Quarter Fiscal 2010 Financial Results and Conference Call
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 01/29/10 at 12:10pm
Analyst Upgrades, Downgrades and Initiations: BKC, CAH, DGX, FII, MAN, URBN, WMT ...
Analyst Upgrades, Downgrades and Initiations: BKC, CAH, DGX, FII, MAN, URBN, WMT ...